AtriCure Shares Outstanding 2010-2025 | ATRC

AtriCure shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
AtriCure Annual Shares Outstanding
(Millions of Shares)
2024 47
2023 46
2022 46
2021 46
2020 42
2019 38
2018 34
2017 32
2016 32
2015 28
2014 26
2013 20
2012 16
2011 16
2010 15
2009 15
AtriCure Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 47
2024-12-31 47
2024-09-30 47
2024-06-30 47
2024-03-31 47
2023-12-31 46
2023-09-30 46
2023-06-30 46
2023-03-31 46
2022-12-31 46
2022-09-30 46
2022-06-30 46
2022-03-31 46
2021-12-31 46
2021-09-30 46
2021-06-30 45
2021-03-31 45
2020-12-31 42
2020-09-30 44
2020-06-30 42
2020-03-31 39
2019-12-31 38
2019-09-30 38
2019-06-30 37
2019-03-31 37
2018-12-31 34
2018-09-30 34
2018-06-30 33
2018-03-31 33
2017-12-31 32
2017-09-30 33
2017-06-30 32
2017-03-31 32
2016-12-31 32
2016-09-30 32
2016-06-30 32
2016-03-31 31
2015-12-31 28
2015-09-30 27
2015-06-30 27
2015-03-31 27
2014-12-31 26
2014-09-30 27
2014-06-30 27
2014-03-31 25
2013-12-31 20
2013-09-30 21
2013-06-30 21
2013-03-31 20
2012-12-31 16
2012-09-30 16
2012-06-30 16
2012-03-31 16
2011-12-31 16
2011-09-30 16
2011-06-30 16
2011-03-31 15
2010-12-31 15
2010-09-30 15
2010-06-30 15
2010-03-31 15
2009-12-31 15
2009-09-30 15
2009-06-30 14
2009-03-31 14
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.645B $0.465B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $219.828B 25.79
Boston Scientific (BSX) United States $156.585B 37.40
Stryker (SYK) United States $152.939B 31.98
EssilorLuxottica (ESLOY) France $137.925B 0.00
Medtronic (MDT) Ireland $117.956B 16.72
Lonza Group Ag (LZAGY) Switzerland $49.343B 0.00
Haleon (HLN) United Kingdom $43.576B 24.87
ResMed (RMD) United States $40.103B 30.12
GE HealthCare Technologies (GEHC) United States $35.596B 16.90
Agilent Technologies (A) United States $33.957B 22.14
Terumo (TRUMY) Japan $25.643B 33.31
Koninklijke Philips (PHG) Netherlands $24.709B 17.34
Insulet (PODD) United States $20.568B 80.74
Zimmer Biomet Holdings (ZBH) United States $18.989B 12.20
Baxter (BAX) United States $14.636B 10.93
Smith & Nephew SNATS (SNN) United Kingdom $13.656B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.891B 23.98
Lantheus Holdings (LNTH) United States $5.010B 12.64
Perrigo (PRGO) Ireland $3.867B 9.80
Prestige Consumer Healthcare (PBH) United States $3.770B 16.84
Haemonetics (HAE) United States $3.587B 16.34
Envista Holdings (NVST) United States $3.515B 29.21
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.138B 23.14
LeMaitre Vascular (LMAT) United States $1.863B 41.65
QuidelOrtho (QDEL) United States $1.764B 12.14
Acuren (TIC) United States $1.367B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.96
AdaptHealth (AHCO) United States $1.294B 13.14
Neogen (NEOG) United States $1.176B 15.06
Phibro Animal Health (PAHC) United States $1.172B 14.98
BioLife Solutions (BLFS) United States $1.063B 0.00
Curaleaf Holdings (CURLF) Canada $0.987B 0.00
InMode (INMD) Israel $0.919B 9.26
Kestra Medical Technologies (KMTS) United States $0.847B 0.00
Tilray Brands (TLRY) Canada $0.704B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
Valneva SE (VALN) France $0.648B 0.00
Owens & Minor (OMI) United States $0.608B 5.04
Evolus (EOLS) United States $0.598B 0.00
CeriBell (CBLL) United States $0.541B 0.00
Surmodics (SRDX) United States $0.524B 0.00
ZimVie (ZIMV) United States $0.524B 23.82
SNDL (SNDL) Canada $0.394B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.358B 0.00
Cresco Labs (CRLBF) United States $0.329B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.97
Quanterix (QTRX) United States $0.324B 0.00
Capricor Therapeutics (CAPR) United States $0.310B 0.00
Sanuwave Health (SNWV) United States $0.306B 0.00
Aurora Cannabis (ACB) Canada $0.269B 79.67
Cerus (CERS) United States $0.260B 0.00
Omeros (OMER) United States $0.256B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.246B 20.77
Biote (BTMD) United States $0.239B 6.72
Verano Holdings (VRNOF) United States $0.238B 0.00
Brainsway (BWAY) Israel $0.227B 60.00
Canopy Growth (CGC) Canada $0.224B 0.00
Sanara MedTech (SMTI) United States $0.222B 0.00
Organigram Global (OGI) Canada $0.198B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.45
High Tide (HITI) Canada $0.184B 0.00
TriSalus Life Sciences (TLSI) United States $0.172B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.157B 0.00
TerrAscend (TSNDF) Canada $0.138B 0.00
FitLife Brands (FTLF) United States $0.120B 14.83
MacroGenics (MGNX) United States $0.105B 0.00
Jushi Holdings (JUSHF) United States $0.104B 0.00
Jin Medical (ZJYL) China $0.104B 0.00
Fonar (FONR) United States $0.099B 12.77
Quipt Home Medical (QIPT) United States $0.093B 0.00
Apyx Medical (APYX) United States $0.091B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Safety Shot (SHOT) United States $0.088B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Veru (VERU) United States $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Agape ATP (ATPC) $0.067B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
United-Guardian (UG) United States $0.039B 13.38
Nephros (NEPH) United States $0.038B 51.43
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00